Comprehensive Study Notes on General Anesthetics
Fundamental Principles and Potency of General Anesthetics
Minimum Alveolar Concentration (MAC):
MAC is defined as the concentration of an anesthetic at which of patients do not respond to a surgical incision.
There is an inverse relationship between MAC and potency; a lower MAC indicates a higher potency, whereas a high MAC value indicates a poorer anesthetic effect.
MAC is influenced by factors such as body temperature, age, and concurrent use of other drugs.
Nitrous oxide () has a very high MAC value (exceeding ), making it relatively weak as a primary anesthetic agent compared to volatile liquids like Halothane.
Solubility and Partition Coefficients:
Blood-Gas Partition Coefficient: This determines the rate of induction and recovery. A smaller coefficient means the drug is less soluble in the blood, allowing the partial pressure in the alveoli and blood to reach equilibrium faster, leading to a more rapid onset of action (induction) and a faster recovery.
Oil-Gas Partition Coefficient: Inversely related to MAC; agents with higher lipid solubility (larger oil-gas coefficient) are generally more potent.
Highly lipid-soluble anesthetics do not necessarily require a higher concentration; rather, as lipid solubility increases, the concentration required for anesthesia generally decreases.
General Characteristics:
Gaseous anesthetics easily cross the placental barrier and can enter the fetus.
can be used to accelerate the induction of other anesthetics (such as Halothane) due to the second gas effect.
Stages and Signs of General Anesthesia
Stage I: Analgesia: The patient experiences a loss of pain sensation but remains conscious.
Stage II: Delirium (Excitement): Characterized by irregular breathing, increased muscle tone, and the first instance of pupil dilation.
Stage III: Surgical Anesthesia:
This stage is characterized by the loss of consciousness, loss of reflex functions, and skeletal muscle relaxation.
Level 2 of Stage III: Specific signs include the second occurrence of pupil dilation and dryness of the eyes.
Stage IV: Medullary Paralysis: This is a critical stage where respiratory and circulatory centers in the medulla are inhibited, which can lead to death if not managed immediately.
Inhalation Anesthetics: Properties and Adverse Effects
Halothane:
Classification: Inhalation liquid anesthetic.
Properties: High potency, but exhibits poor analgesic properties and poor skeletal muscle relaxation.
Side Effects: Can cause bradycardia (slowed heart rate), hypotension (decreased blood pressure), and decreased cardiac output.
Toxicities: It has the highest risk of hepatotoxicity (liver damage) among common anesthetics. It is also associated with Malignant Hyperthermia.
Cardiac Sensitization: It sensitizes the heart to catecholamines (like epinephrine), which can lead to dangerous cardiac arrhythmias or even cardiac arrest if epinephrine is administered concurrently.
Post-operative effect: Less likely to cause post-operative vomiting compared to agents like Ether.
Nitrous Oxide (; Laughing Gas):
Properties: Fast-acting induction and recovery, non-flammable, and possesses excellent analgesic properties. However, it provides poor skeletal muscle relaxation and has low anesthetic potency (high MAC).
Methoxyflurane:
Noted for having the highest potential for nephrotoxicity (kidney damage) because of the release of fluoride ions during metabolism.
Enflurane:
Provides good skeletal muscle relaxation.
Isoflurane:
A commonly used stable inhalation agent; less likely to cause arrhythmias compared to Halothane.
Cyclopropane:
Noted for being highly flammable and explosive, which severely limits its clinical use.
Ether (Diethyl Ether):
Notorious for causing significant post-operative nausea and vomiting.
Intravenous (IV) Anesthetics
Thiopental:
Classification: Ultra-short-acting Barbiturate.
Mechanism of Action Termination: Its effect is terminated not by rapid metabolism or excretion, but by Redistribution. After injection, the drug level in the brain drops rapidly as it redistributes from the brain (high-blood-flow area) to lipid-rich adipose tissues.
Clinical Use: Often used for rapid induction of anesthesia before switching to inhalation agents.
Ketamine:
Classification: Dissociative anesthetic; acts as an NMDA receptor antagonist.
Effects: Induces a state of "dissociative anesthesia" (the patient appears awake but is unconscious and feels no pain). It stimulates the sympathetic nervous system, leading to increased heart rate and blood pressure.
Contraindications: It increases intracranial pressure, making it contraindicated for patients with Central Nervous System (CNS) tumors.
Respiratory Impact: Unlike many other anesthetics, it causes less respiratory depression.
Etomidate:
Clinical Limitation: Its use is strictly limited because it inhibits the production of adrenal steroids (adrenal suppression).
Propofol:
An intravenous anesthetic used for both induction and maintenance of anesthesia.
Premedication and Adjunct Drugs
Anticholinergics (e.g., Atropine):
Purpose: Administered before surgery to reduce salvage and bronchial secretions (preventing aspiration), and to protect against reflex bradycardia.
Benzodiazepines (e.g., Diazepam, Midazolam):
Purpose: Used to relieve patient anxiety, induce sedation, and can prevent convulsions associated with high doses of local anesthetics.
Opioids (e.g., Meperidine/Demerol, Fentanyl):
Purpose: Primarily used for analgesia (pain relief) before or during surgery.
Antihistamines (e.g., Hydroxyzine):
Purpose: Provides sedation and antiemetic (anti-vomiting) effects.
Muscle Relaxants (e.g., Succinylcholine):
Used to achieve skeletal muscle relaxation. When combined specifically with Halothane, there is a significantly increased risk of developing Malignant Hyperthermia.
Drugs NOT typically used as premedication: Anti-adrenergics.
Clinical Warnings and Specific Conditions
Malignant Hyperthermia: A life-threatening hypermetabolic state often triggered by the combination of volatile inhalation anesthetics (like Halothane or Enflurane) and the depolarizing muscle relaxant Succinylcholine.
Post-Operative Nausea and Vomiting (PONV): Highly associated with Ether and Cyclopropane; less common with Halothane.
Adrenal Suppression: Specifically associated with Etomidate.
Nephrotoxicity: Primarily a concern with Methoxyflurane due to fluoride metabolites.